Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.
Register for email alerts
You're only seeing a fraction of our data
Registration is free and easy and gives you unlimited access to:
  • Over 15,000 full fund manager factsheets and career histories
  • Email updates covering the best performing fund managers
  • All the latest fund manager job moves
  • Investment analysis and our award winning editorial content
Register Sign in
Please see terms and conditions for restrictions on use of Citywire's Fund Manager database.
Steven Kornfeld

Steven Kornfeld

This manager is not currently tracked by Citywire in Gibraltar View performance globally
Citywire

For news and performance for funds and managers available



About Steven Kornfeld

Steven Kornfeld graduated from the Wharton School of Business at the University of Pennsylvania and Northwestern University’s Kellogg Graduate School of Management and holds a BA in business and an MBA. He has been managing funds for over ten years and is currently a fund manager at Franklin Templeton where he runs US equities. Before this he worked in private equity and previously as a sell-side research analyst where he specialised in emerging growth companies. Steven is a CFA Charterholder.

Are you Steven Kornfeld?

Citywire Rating: Not Eligible

Steven Kornfeld does not currently have the required track record to be eligible for a Citywire Rating. See methodology

2012

  • JNot rated in Jul 2012
  • ANot rated in Aug 2012
  • SNot rated in Sep 2012
  • ONot rated in Oct 2012
  • NNot rated in Nov 2012
  • DNot rated in Dec 2012

August 2007 - Starts managing first fund

Related News

Franklin Templeton boosts blockbuster biotech team

US giant assigns third person to oversee dedicated equity investment vehicle, Citywire Selector learns.

Politics will not 'kill the golden goose', says biotech specialist

Franklin Templeton's Evan McCulloch is braced for potential disruption from Presidential race but believes idiosyncratic stories can stand up to the task.

Franklin Templeton reopens blockbuster biotech fund

US giant ends soft-close measures after 18-months following fall in assets under management and market correction.

Biotech manager departs Franklin Templeton

Sector specialist ends three-year stint on soft-closed strategy with pharma expert named as replacement, Citywire Global has learned.

Manager Tracker: festive changes revealed

With Christmas now upon us, Citywire Global reveals the manager moves to have hit our radar.